Palonosetron
Netupitant/palonosetron
Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial
Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
Granisetron/ondansetron/palonosetron
Cisplatin/dexamethasone/netupitant/palonosetron
Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects